Who are Jupiter Neurosciences, Inc.'s main suppliers?

Jupiter Neurosciences, Inc. (JUNS) key suppliers include: D-BORAL-CAPITAL-LLC, DOMINANT-TREASURE, DOMINANT-TREASURE-HEALTH-COMPANY-LIMITED, LONGEVITY-TECHNOLOGY-GROUP-LIMITED, OPTIMIZE-WELLNESS-LIMITED and 3 more. View the full supplier network at chainsifter.com/chain/JUNS.

Who are Jupiter Neurosciences, Inc.'s major customers?

Jupiter Neurosciences, Inc. (JUNS) key customers include: ABITOS-ADVISORS-LLC, AD-LLC, AQUANOVA-AG, ASSOCIATES-LLC, ASSURANCE-DIMENSIONS-LLC and 11 more. View the full customer network at chainsifter.com/chain/JUNS.

What sector is Jupiter Neurosciences, Inc. in?

Jupiter Neurosciences, Inc. (JUNS) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Jupiter Neurosciences, Inc. Supplier List (JUNS): 8 Verified Suppliers

8Suppliers

16Customers

3Debt Items

4Related Chains

Source-Backed Evidence Depth

Jupiter Neurosciences, Inc. (JUNS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

28Total relationships

3Distinct source URLs

11High confidence

0.733Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Jupiter Neurosciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
D-BORAL-CAPITAL-LLC	D-BORAL-CAPITAL-LLC	92%	The Company entered into a placement agency agreement with D. Boral Capital LLC pursuant to which the Company engaged D. Boral as the placement agent in connection with the Offering.
DOMINANT-TREASURE	DOMINANT-TREASURE	90%	For the three months ended March 31, 2026 and 2025, the Company recorded consulting expense of $ 189,041 in each period related to the Dominant Treasure agreement.
DOMINANT-TREASURE-HEALTH-COMPANY-LIMITED	DOMINANT-TREASURE-HEALTH-COMPANY-LIMITED	90%	The Company entered into a Strategic Service Agreement with DOMINANT TREASURE HEALTH COMPANY LIMITED to provide services to advance the business objectives of the Company in China and Southeast Asia.
LONGEVITY-TECHNOLOGY-GROUP-LIMITED	LONGEVITY-TECHNOLOGY-GROUP-LIMITED	90%	a Product Services Agreement with Longevity Technology Group Limited providing manufacturing guidance
OPTIMIZE-WELLNESS-LIMITED	OPTIMIZE-WELLNESS-LIMITED	90%	a CRO Services Agreement with Optimize Wellness Limited providing clinical trial guidance in China, Malaysia, and Singapore
REGIS-HEALTHCARE-GROUP-LIMITED	REGIS-HEALTHCARE-GROUP-LIMITED	90%	a Regulatory Services Agreement with Regis Healthcare Group Limited providing regulatory strategy and guidance
AQUANOVA-AG	AQUANOVA-AG	85%	On September 13, 2016, the Company entered into a Development, Collaboration and License Agreement with Aquanova AG, a German company in the field of development, manufacturing and selling of colloid…
SBET	Sharplink, Inc.	72%	Reciprocal relationship from SBET graph: . In addition, in the event of a termination of one or more of our custody agreements, the Company would be required to contract with an alternative custodian…

Jupiter Neurosciences, Inc. Customers

Ticker	Name	Confidence	Evidence
ABITOS-ADVISORS-LLC	ABITOS-ADVISORS-LLC	62%	RA and ASSOCIATES, LLC TAMPA BAY: 4920 W Cypress Street, Suite 102 \| Tampa, FL 33607 \| Office: 813.443.5048 \| Fax: 813.443.5053 JACKSONVILLE: 7800 Belfort Parkway, Suite 290 \| Jacksonville, FL 32256 …
AD-LLC	AD-LLC	62%	RA and ASSOCIATES, LLC TAMPA BAY: 4920 W Cypress Street, Suite 102 \| Tampa, FL 33607 \| Office: 813.443.5048 \| Fax: 813.443.5053 JACKSONVILLE: 7800 Belfort Parkway, Suite 290 \| Jacksonville, FL 32256 …
AQUANOVA-AG	AQUANOVA-AG	62%	elp us comply, and in many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with rules applicable to the particular jurisdiction. However, there are s…
ASSOCIATES-LLC	ASSOCIATES-LLC	62%	RA and ASSOCIATES, LLC TAMPA BAY: 4920 W Cypress Street, Suite 102 \| Tampa, FL 33607 \| Office: 813.443.5048 \| Fax: 813.443.5053 JACKSONVILLE: 7800 Belfort Parkway, Suite 290 \| Jacksonville, FL 32256 …
ASSURANCE-DIMENSIONS-LLC	ASSURANCE-DIMENSIONS-LLC	62%	RA and ASSOCIATES, LLC TAMPA BAY: 4920 W Cypress Street, Suite 102 \| Tampa, FL 33607 \| Office: 813.443.5048 \| Fax: 813.443.5053 JACKSONVILLE: 7800 Belfort Parkway, Suite 290 \| Jacksonville, FL 32256 …
DOMINANT-TREASURE-HEALTH-COMPANY-LIMITED	DOMINANT-TREASURE-HEALTH-COMPANY-LIMITED	62%	uch as Liposomal and micellar technologies are widely used by many companies to enhance the absorption of key actives, similar to Nugevia’s approach, purity and clinical validation. Furthermore, comp…
JUPITER-NEUROSCIENCES-INC-BUSINESS-OVERVIEW-JUPI	JUPITER-NEUROSCIENCES-INC-BUSINESS-OVERVIEW-JUPI	62%	term service and consulting agreements with third party providers for research, development, testing and manufacturing services. The agreements generally provide termination, at any time by either pa…
KELUN-INDUSTRIAL-GROUP	KELUN-INDUSTRIAL-GROUP	62%	uch as Liposomal and micellar technologies are widely used by many companies to enhance the absorption of key actives, similar to Nugevia’s approach, purity and clinical validation. Furthermore, comp…
LONGEVITY-TECHNOLOGY-GROUP-LIMITED	LONGEVITY-TECHNOLOGY-GROUP-LIMITED	62%	uch as Liposomal and micellar technologies are widely used by many companies to enhance the absorption of key actives, similar to Nugevia’s approach, purity and clinical validation. Furthermore, comp…
LONGEVITY-TECHNOLOGY-GROUP-LIMITED-REGIS-HEALTHC	LONGEVITY-TECHNOLOGY-GROUP-LIMITED-REGIS-HEALTHC	62%	product candidate may not be predictive of the results that will be obtained in later stage clinical trials of the product candidate. 25 The success of other product candidates we may develop will de…
OPTIMIZED-WELLNESS-LIMITED	OPTIMIZED-WELLNESS-LIMITED	62%	product candidate may not be predictive of the results that will be obtained in later stage clinical trials of the product candidate. 25 The success of other product candidates we may develop will de…
OPTIMIZE-WELLNESS-LIMITED	OPTIMIZE-WELLNESS-LIMITED	62%	uch as Liposomal and micellar technologies are widely used by many companies to enhance the absorption of key actives, similar to Nugevia’s approach, purity and clinical validation. Furthermore, comp…
OVERVIEW-JUPITER-NEUROSCIENCES-INC	OVERVIEW-JUPITER-NEUROSCIENCES-INC	62%	fs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking stat…
REGIS-HEALTHCARE-GROUP-LIMITED	REGIS-HEALTHCARE-GROUP-LIMITED	62%	uch as Liposomal and micellar technologies are widely used by many companies to enhance the absorption of key actives, similar to Nugevia’s approach, purity and clinical validation. Furthermore, comp…
SICHUAN-KELUN-PHARMACEUTICAL-CO-LTD	SICHUAN-KELUN-PHARMACEUTICAL-CO-LTD	62%	uch as Liposomal and micellar technologies are widely used by many companies to enhance the absorption of key actives, similar to Nugevia’s approach, purity and clinical validation. Furthermore, comp…
YA-II-PN-LTD	YA-II-PN-LTD	62%	term service and consulting agreements with third party providers for research, development, testing and manufacturing services. The agreements generally provide termination, at any time by either pa…

Jupiter Neurosciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
JUNS-DEBT	Debt stack $5.3M	90%	Market cache reports total debt of $5.3M.
JUNS-DEBT-10468	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-10-27.
JUNS-DEBT-10467	Warrants outstanding: 109376	90%	xbrl warrant detail from xbrl 2025-06-22.

Jupiter Neurosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Jupiter Neurosciences, Inc..

Jupiter Neurosciences, Inc. Ownership

Holder	Name	Confidence	Evidence
JUNS-OWNER-VESTOR-CAPITAL-LLC	VESTOR CAPITAL, LLC	90%	13F overlay lists VESTOR CAPITAL, LLC as top holder; 10 tracked holders.

Jupiter Neurosciences, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SBET	Sharplink, Inc.	100.00	1	['supplier']
CAPC	Capstone Companies, Inc.	50.00	2
GLXY	Galaxy Digital	50.00	2
FISI	Financial Institutions, Inc.	50.00	2

Jupiter Neurosciences, Inc. Supply Chain